A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug ...

A new non-opioid painkiller, JournaVX, has received approval from the FDA, marking the first new type of pain medication in ...

The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.

Vertex Pharmaceuticals could soon capture $10 billion in sales of non-opioid painkillers, an analyst said Friday as Vertex stock jumped.

Patients seeking an opioid-free way to handle pain experienced in the short-term will soon have a new option.

The S&P 500 declined by 0.5% on Friday, Jan. 31, as investors digested the White House’s proposed tariffs on Canada, China, and Mexico.

Vertex Pharmaceuticals (VRTX) closed up more than +5% after receiving FDA approval for its non-opioid analgesic Journavx to treat moderate-to-severe acute pain in adults. AbbVie (ABBV) closed up by ...